DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma.
Priya ChoudhryMargarette C MarianoHuimin GengThomas G MartinJeffrey L WolfSandy W WongNina ShahArun P WiitaPublished in: Leukemia (2019)